Segmented siRNA with 3' Overhangs for Targeted Gene Silencing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating siRNA are limited in their ability to effectively induce RNA interference for therapeutic applications, particularly in targeting specific genes associated with pathological conditions, as they lack efficiency and specificity in inhibiting gene expression.
Innovation Solution
The method involves synthesizing short double-stranded RNA molecules with specific nucleotide lengths and 3' overhangs, which are designed to target specific mRNA sequences, allowing for the formation of double-stranded RNA molecules with single-stranded regions that can mediate RNA interference and DNA methylation, enhancing their stability and therapeutic potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods for generating siRNA are used, then the process is simple, but the efficiency and specificity in inhibiting gene expression is insufficient
Solution Approach 1:
The siRNA is segmented into three distinct nucleotide strands (first, second, and third strands) with specific length ranges. The first strand is 10-25 nucleotides, the second strand is 1-10 nucleotides, and the third strand is 1-10 nucleotides. This segmentation allows each strand to perform specific functions: the first strand provides the primary targeting sequence, while the second and third strands form the 3' overhang structure that enhances stability and RNAi activity.
Solution Approach 2:
Different regions of the siRNA structure are given different properties. The 5' end region (first strand) has specific sequence identity to the target mRNA for recognition and binding. The 3' end region (second and third strands) forms a single-stranded overhang with specific length (1-10 nucleotides) that provides structural stability and enhances RNA interference activity. This local differentiation of structure and function improves both efficiency and specificity.
2Productivity
If siRNA is designed with specific nucleotide lengths and 3' overhangs, then RNA interference efficiency is improved, but the manufacturing process becomes more complex
Solution Approach 1:
The three nucleotide strands are synthesized separately with predetermined lengths and sequences before assembly. The first strand is synthesized to be 10-25 nucleotides, while the second and third strands are synthesized to be 1-10 nucleotides each. This preliminary synthesis allows for precise control over the final siRNA structure, including the formation of the 3' overhang, without requiring complex post-synthesis modifications.
Solution Approach 2:
The three separate nucleotide strands self-assemble through complementary base pairing to form the final double-stranded RNA structure with the characteristic 3' overhang. The second and third strands automatically pair with each other to form the overhang region, while the first strand pairs with the complementary region. This self-assembly process eliminates the need for complex enzymatic ligations or additional processing steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables targeted and efficient RNA interference, effectively inhibiting the expression of genes associated with pathological conditions, such as VEGF, by forming double-stranded RNA molecules with specific nucleotide identities and 3' overhangs, demonstrating improved efficacy in reducing target mRNA levels.
Implementation Method 1
combining the synthesized RNA strands under conditions, wherein a double-stranded RNA molecule is formed
Data Source
Figure 1
AI summary
Double-stranded RNA of about 19 to about 25 nucleotides in length capable of regulating gene expression by RNA interference is provided. Such double-stranded RNA are particularly useful for treating disease or conditions associated with a target mRNA or gene. Methods of manufacture and methods of use of the double-stranded RNA are also provided.